From global to local: addressing the threat of AMR to STI control

Thursday, January 9, 2020 - 9:00am to Friday, January 10, 2020 - 5:00pm

January 9-10, 2020

09:00 - 17:00

LSHTM, Keppel Street
United Kingdom


Anti-microbial resistance (AMR) in sexually transmitted infections (STIs) is a major public health threat, with Neisseria gonorrhoeae being designated as a “high priority antibiotic resistant pathogen” by the World Health Organization (WHO). In the United Kingdom, the O’Neill review recommended that no antibiotics should be prescribed before an appropriate diagnostic test result is available in high-income countries. This is ambitious for the UK, let alone for most low- and middle-income countries where syndromic management is commonplace. In the absence of new diagnostics, antimicrobials and vaccines, combined with limited AMR surveillance data to inform national and global STI programming, there will be serious global sexual and reproductive health consequences.

This two-day conference will bring together experts working at the interface of antimicrobial resistance (AMR) and STI research, policy and practice. Themes covered will include surveillance, treatment guidelines, new treatment initiatives, new diagnostic initiatives, antibiotic stewardship, and vaccines.

The aims of the conference are to:

  • Develop a network to share knowledge and experiences of effective strategies and bottlenecks for tackling STI AMR, both locally and globally
  • Identify bottlenecks and solutions for tackling STI AMR
  • Develop a short- and long-term action plan on STIs and AMR


Grant support for ASP provided by


Unrestricted financial support provided by

Bentson FoundationBDUnited Health Group

    Nabriva Therapeutics 
Become an underwriter»